BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34248109)

  • 1. Superiority of Cystatin C over Creatinine for Early Diagnosis of Acute Kidney Injury in Pediatric Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.
    Yamazoe T; Akagawa S; Matsuno R; Akagawa Y; Yamanouchi S; Omachi T; Kimata T; Tsuji S; Kaneko K
    Tohoku J Exp Med; 2021 Jul; 254(3):163-170. PubMed ID: 34248109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure.
    Wan ZH; Wang JJ; You SL; Liu HL; Zhu B; Zang H; Li C; Chen J; Xin SJ
    World J Gastroenterol; 2013 Dec; 19(48):9432-8. PubMed ID: 24409073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.
    Zappitelli M; Greenberg JH; Coca SG; Krawczeski CD; Li S; Thiessen-Philbrook HR; Bennett MR; Devarajan P; Parikh CR;
    JAMA Pediatr; 2015 Jun; 169(6):583-91. PubMed ID: 25844892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C compared to serum creatinine as a marker of acute kidney injury in critically ill neonates.
    Hidayati EL; Utami MD; Rohsiswatmo R; Tridjaja B
    Pediatr Nephrol; 2021 Jan; 36(1):181-186. PubMed ID: 32594242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study.
    Sinna MM; Altaf FMN; Mosa OF
    Curr Pharm Des; 2019; 25(10):1122-1133. PubMed ID: 31096894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shrunken Pore Syndrome: A New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast-Associated Acute Kidney Injury.
    Zhang LW; Luo MQ; Xie XW; You ZB; Zeng JL; Lin MQ; Chen LC; Lin KY; Guo YS
    J Am Heart Assoc; 2023 Jan; 12(1):e027980. PubMed ID: 36565177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of acute kidney injury by serum cystatin C in critically ill children.
    Ataei N; Bazargani B; Ameli S; Madani A; Javadilarijani F; Moghtaderi M; Abbasi A; Shams S; Ataei F
    Pediatr Nephrol; 2014 Jan; 29(1):133-8. PubMed ID: 23989306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children.
    Bai Z; Fang F; Xu Z; Lu C; Wang X; Chen J; Pan J; Wang J; Li Y
    BMC Pediatr; 2018 Jun; 18(1):192. PubMed ID: 29907141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis.
    Vijay P; Lal BB; Sood V; Khanna R; Alam S
    Eur J Pediatr; 2021 Nov; 180(11):3287-3295. PubMed ID: 33978827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Cystatin C for the Diagnosis of Acute Kidney Injury in Patients Admitted in the Emergency Department.
    Bongiovanni C; Magrini L; Salerno G; Gori CS; Cardelli P; Hur M; Buggi M; Di Somma S
    Dis Markers; 2015; 2015():416059. PubMed ID: 26170529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure.
    Jha P; Jha AK; Dayal VM; Jha SK; Kumar A
    Indian J Gastroenterol; 2021 Dec; 40(6):563-571. PubMed ID: 34981441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides.
    Lau L; Al-Ismaili Z; Harel-Sterling M; Pizzi M; Caldwell JS; Piccioni M; Lands LC; Mottes T; Devarajan P; Goldstein SL; Bennett MR; Zappitelli M
    Pediatr Nephrol; 2017 Jan; 32(1):163-171. PubMed ID: 27743042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery.
    Zappitelli M; Krawczeski CD; Devarajan P; Wang Z; Sint K; Thiessen-Philbrook H; Li S; Bennett MR; Ma Q; Shlipak MG; Garg AX; Parikh CR;
    Kidney Int; 2011 Sep; 80(6):655-62. PubMed ID: 21525851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?
    Lagos-Arevalo P; Palijan A; Vertullo L; Devarajan P; Bennett MR; Sabbisetti V; Bonventre JV; Ma Q; Gottesman RD; Zappitelli M
    Pediatr Nephrol; 2015 Apr; 30(4):665-76. PubMed ID: 25475610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate in the Follow-Up of Patients Recovering from a Stage-3 AKI in ICU.
    Nateghi Haredasht F; Viaene L; Vens C; Callewaert N; De Corte W; Pottel H
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36555881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute kidney injury assessed by cystatin C after transcatheter aortic valve implantation and late renal dysfunction.
    Johansson M; Nozohoor S; Bjursten H; Kimblad PO; Sjögren J
    J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):960-5. PubMed ID: 24315756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery.
    Shlipak MG; Coca SG; Wang Z; Devarajan P; Koyner JL; Patel UD; Thiessen-Philbrook H; Garg AX; Parikh CR;
    Am J Kidney Dis; 2011 Sep; 58(3):366-73. PubMed ID: 21601336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C level is associated with the recovery of renal function in cancer patients after onset of acute kidney injury.
    Li R; Wang X; Zhao X; Zhang X; Chen H; Ma Y; Liu Y
    Ann Palliat Med; 2021 Feb; 10(2):2158-2166. PubMed ID: 33725771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors.
    Latoch E; Konończuk K; Taranta-Janusz K; Muszyńska-Rosłan K; Szymczak E; Wasilewska A; Krawczuk-Rybak M
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):741-749. PubMed ID: 33052454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.